Meningococcal (Meningitis)

According to the CDC, protection from the meningitis quadrivalent vaccine lasts about five years, meaning that the shot your doctor is recommending is intended to protect your son through college. This shot covers four strains of meningitis - Strains A, C, Y, and W-135. 

According to a March 2019 peer-reviewed article published by the Centers for Disease Control, all college outbreaks in the past seven years (since 2011) have been caused by Type B meningitis, which is a strain not covered by the quadrivalent vaccine. Source (2) CDC March 2019 peer reviewed article. 

Currently, the ACIP does not universally recommend the MenB vaccine which would cover serogroup B meningococcal disease which is causing the outbreaks on college campuses. The only universal recommendations are the initial and booster doses of the quadrivalent vaccine (again, the one your doctor is recommending).  In other words, the strain causing the meningitis outbreaks on campuses per the CDC, serogroup B, is covered by the MenB shot, which is not universally recommended by the CDC. Source: (3) ACIP vaccine recomendations

In Texas specifically, since 2011, the number of cases of meningitis has varied between 17 and 37 cases per year according to DSHS. Of the 17 cases in 2017 – which is the most recent year for which data is available on the DSHS website – only THREE were school or college aged children. The other 14 cases were people 30 years of age and older, and 7 being individuals over 60.  source: (4) Texas DHS

DSHS does not publicly report on the strains involved, but the three involving school or college-aged children were likely Strain B, again a strain not covered by the quadrivalent vaccine.

There are four FDA approved meningococcal vaccines currently available for use in the United States. Two vaccines, Menectra (Sanofi Pasteur) and Menveo (Novartis/GlaxoSmithKline) conjugate vaccines target serogroups A, C, Y and W-135 meningococcal bacteria and two vaccines, BEXSERO (Novartis/GlaxoSmithKline) and TRUMENBA (Wyeth/Pfizer) recombinant vaccines target serogroup B meningococcal bacteria.5

Meningococcal (Meningitis) Package Inserts can all be found below. 

• https://www.vaccineshoppe.com/image.cfm?doc_id=12580..." rel="noopener" target="_blank">Meningococcal ACWY
  Menactra Package Insert; Sanofi Pasteur
• Menveo Package Insert; Glaxo Smith Kline *not available in the US*
• Menomune A/C/Y/W-135 Package Insert;  Sanofi Pasteur
• Menhibrix Package Insert; GlaxoSmithKline
• https://gsksource.com/.../Pres.../Bexsero/pdf/BEXSERO.PDF..." rel="noopener" target="_blank">Meningococcal B
  Bexsero Product Approval-Bexsero Package Insert; Novartis
• Trumenba Package Insert; Pfizer 

The World Health Organization reports 109 that cases of meningococcal meningitis (serogroup have increased markedly in North America in recent years. So, there seems to be no demonstrated savings in illness in children. On top of all this there seems to be an association between DPT vaccination and invasive Hib disease. Dr Viera Scheibner comments on the reported 399% increase in Hib disease since the early 1940s and asks,110  "Why have developed countries experienced such an increase of invasive infections in the last 40 years?... The best demonstrable common factor in this period is a documented push for mass vaccination."

Side Effects:
According to the CDC, at least 50 percent of individuals receiving meningococcal vaccines targeting meningococcal serogroups A, C, Y, and W-135 (Menactra or Menveo) experience mild side effects such as pain or redness at the injection site and a small number also report joint pain and muscle aches following vaccination. Additionally the CDC warns that persons receiving any vaccine may collapse (faint), experience a severe allergic reaction, severe pain and limited mobility to the vaccinated limb, and even serious injury and death.  Source: (5) CDC

As of October 27, 2023, there have been 46,028 reports of meningococcal vaccine reactions, hospitalizations, injuries and deaths following meningococcal vaccinations made to the federal Vaccine Adverse Events Reporting System (VAERS), including 265 related deaths, 4,894 hospitalizations, and 605 related disabilities. Source: (6) VAERS 

Adverse events reported by Wyeth Pharmaceuticals (Pfizer)  in the pre-licensing clinical trials of TRUMENBA vaccine included: pain, swelling, and redness at the injection site; headache; fever; vomiting and diarrhea; fatigue; chills; muscle and joint pain; nervous system disorders; ligament strain; oropharyngeal pain; eye disorders; severe vertigo, chills, and headache; severe vomiting with fever; anaphylaxis; hydrocephalus; post-infectious arthritis; deep vein thrombosis; Type 2 diabetes mellitus; contact dermatitis; decreased appetite; migraine; asthma; hypothyroidism; scoliosis; Crohn's disease; exacerbation of psoriasis; celiac disease; exacerbation of celiac disease; autoimmune thyroiditis; acute idiopathic thrombocytopenia purpura (ITP); Sydenham’s chorea; IgA nephropathy; hyperthyroidism; rheumatoid arthritis; Bell’s Palsy; lymphoid tissue hyperplasia; psychiatric disorders; appendicitis; cellulitis; depression; thymic disorder; extremity weakness; appendicitis; nodular fasciitis; epiphysiolysis; bipolar disorder; leg and wrist fracture; abdominal pain; hemorrhoids; and biliary dyskinesia. Source: (7) Wyeth Pharmasuticles ( Pfizer) 

“Meningitis is not a transmissible disease, we do not "catch" it from one another. My first lesson in vaccine propaganda is when I learned, back in the forties, that the "epidemics" of meningitis amongst military recruits were not epidemics but clusters, and the second thing I learned was that only the freshly vaccinated recruits "caught" meningitis. The mess sergeant didn't, the drill sergeant didn't, only the recruits did. Not even the girls who worked at the base exchanges and service clubs, with whom the recruits played kissy face "caught" meningitis - only the freshly vaccinated recruits "caught" it.......In over thirty years of clinical practice I have never seen an infectious hepatitis "caught" by another member of a household and believe me when I say I really looked high and low for one of those. If I found one I would look for a source of the poisoning, not for a germ or a virus,” Daniel H Duffy Sr. DC.

*Cases of meningitis and septicaemia have fallen from about 4,000 a year in the late 1990s to 2,446 last year following the introduction of a vaccine against meningitis C in November 1999. But in a bizarre twist the number of deaths rose last year by 17 per cent from 317 to 370 and is not far below the level before the vaccine was introduced. [Media September 20, 2004] Meningitis vaccinations 'blamed' for rise in deaths.  When I was in high school, my parents had me vaccinated for meningitis. Following my meningitis vaccination, I ended up in the hospital with a major infection that attacked every area of my system. My parents told me that for the first two days that I was hospitalized I did not even recognize them. The doctors performed a lumbar puncture on me. This procedure involved freezing my mid-section so the doctors could insert a large needle into the pit of my spinal cord to withdraw fluid for testing. Their diagnosis was meningitis. I remained hospitalized for three weeks. They did not want to even consider that my meningitis vaccination could have caused my nearly fatal disease,” Vaccine Safety Manual by Neil Z. Miller (p.337).

“When notifications of meningitis (from MMR vaccine) from physicians were included; when the vaccine records of hospital cases of meningitis were included; when cross linkage of vaccine records from laboratory reports (4 laboratories) was performed and included the figure was increased to 1 in 11,000. It should be noted that in the case of one particular laboratory, this was 1 in 4,000,” Paul Shattock and Dawn Savery, Autism Research Unit, University of Sunderland, Sunderland, UK.

“When I heard about the 14 year old boy who died of group C meningitis I remember wondering how soon beforehand he had had his BCG vaccination (another vaccine with a ‘live’ organism),” Dr. Jayne L M Donegan.

"Every time you hear of the tragic death of an infant, carried off in the first weeks of life by ‘viral meningitis’, you have the right to suspect that BCG is at work, even if the autopsy confirms a viral diagnosis. My wife lived through this tragedy in a major Swiss hospital where she worked. The autopsy of the child revealed the tubercular nature of the ‘viral’ meningitis following a BCG inoculation, but all the assistants and nurses had received very clear instructions to say nothing or risk terrible consequences. As with all secret societies, the law of silence is absolute among doctors,” Dr. Jean Elmiger; Rediscovering Real Medicine ISBN 1862041997.

"The use of Hib vaccines has displaced haemophillus as a cause of disease and death, but other organisms like the far more serious, and more untreatable pneumococcus or other bacterial meningitis types have risen to take the place of Hib as causes of meningitis,” Hilary Butler.

"In Minnesota, a state epidemiologist concluded that the Hib vaccine increases the risk of illness when a study revealed that vaccinated children were *five times* more likely to contract meningitis than unvaccinated children,” Dr. Mercola. 

"Four of the medical experts advising the Government on whether the new meningitis C vaccine is safe have links to one or more of the drug companies that produce it......Professor Janet Darbyshire, a member of the Government's Committee on Safety of Medicines, had received support for academic research from US firms Wyeth and Chiron, who produce the two main meningitis products being used on children in Britain....three members of the Joint Committee on Vaccination and Immunisation had declared interests in vaccine manufacturers...Dr David Goldblatt of the Institute of Child Health, has served on an expert advisory panel for Wyeth and received research grants from Wyeth and North American Vaccines, which produces a third meningitis C drug to be introduced this year. Another, Professor Keith Cartwright of the University of Bristol, received funding from the drug industry to 'evaluate candidate meningicoccal vaccines,” Martin Bright and Tracy McVeigh, Sunday Observer, UK; September 3, 2000. 

The aim of this retrospective study was to evaluate the incidence and the characteristics of spontaneously reported aseptic meningitis (AM) in France following mumps vaccination with monovalent or multivalent vaccines containing the Urabe strain. Fifty-four cases of AM were reported to the regional drug surveillance centres or to the manufacturer from the time each vaccine was launched up until June 1992. Twenty cases were associated with the time of administration of a monovalent mumps vaccine and 34 with a trivalent measles, mumps and rubella vaccine (MMR). A mumps virus was isolated in four cases in the cerebrospinal fluid and an Urabe-like strain was characterized twice by polymerase chain reaction (PCR). Source: (10)